Stay updated with breaking news from Approved Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA guides the transition from emergency-use-labeled Paxlovid to approved labeling, impacting dispensing sites, providers, and patients.
/PRNewswire/ -- Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative...
/PRNewswire/ -- Tris Pharma, Inc. ("Tris") a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today the decision by...
/PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a fully integrated pharmaceutical company with a robust portfolio of CNS products announced that the U.S. Court of...
(2) NEW YORK CITY (dpa-AFX) - Today's Daily Dose brings you news about Lexicon's regulatory update on Sotagliflozin in heart failure; FDA approval of Pfizer's XALKORI in a new indication; Bicycle's pipeline progress update and Organogenesis' progress in knee osteoarthritis trial. Read on. 1. Bicycle Rides High on Pipeline Progress Update Shares of Bicycle Therapeutics plc (BCYC) touched a new high on Thursday on the back of its pipeline progress update. The company's lead drug candidate BT1718 is progressing in the phase IIa portion of the Cancer Research UK sponsored phase I/IIa clinical t...